{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:09:23Z","timestamp":1792069763356,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:00:00Z","timestamp":1722729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:00:00Z","timestamp":1722729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Institute of the National Institutes of Health","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10549-024-07440-5","type":"journal-article","created":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T02:01:42Z","timestamp":1722736902000},"page":"491-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Oral minoxidil for late alopecia in cancer survivors"],"prefix":"10.1007","volume":"208","author":[{"given":"Alyce Mei-Shiuan","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Reingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwami F.","family":"Ketosugbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kraehenbuehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Dusza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"Gajria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana E.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline F.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany A.","family":"Traina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica N.","family":"Fornier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Gucalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Rotemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Dauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari B.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Markova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,4]]},"reference":[{"issue":"1","key":"7440_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"7440_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","volume":"80","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Shapiro J, Goldfarb S et al (2019) Hair disorders in patients with cancer. J Am Acad Dermatol 80(5):1179\u20131196. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.055","journal-title":"J Am Acad Dermatol"},{"issue":"21","key":"7440_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1200\/jco.2013.54.2258","volume":"32","author":"HJ Burstein","year":"2014","unstructured":"Burstein HJ, Temin S, Anderson H et al (2014) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol 32(21):2255\u20132269. https:\/\/doi.org\/10.1200\/jco.2013.54.2258","journal-title":"J Clin Oncol"},{"issue":"5","key":"7440_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","volume":"80","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Shapiro J, van den Hurk C et al (2019) Hair disorders in cancer survivors. J Am Acad Dermatol 80(5):1199\u20131213. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.056","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"7440_CR5","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1634\/theoncologist.2013-0193","volume":"18","author":"V Saggar","year":"2013","unstructured":"Saggar V, Wu S, Dickler MN, Lacouture ME (2013) Alopecia with endocrine therapies in patients with cancer. Oncologist 18(10):1126\u20131134. https:\/\/doi.org\/10.1634\/theoncologist.2013-0193","journal-title":"Oncologist"},{"issue":"5","key":"7440_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5301\/tj.5000376","volume":"101","author":"L Moscetti","year":"2015","unstructured":"Moscetti L, Agnese Fabbri M, Sperduti I et al (2015) Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment? Tumori 101(5):469\u2013473. https:\/\/doi.org\/10.5301\/tj.5000376","journal-title":"Tumori"},{"issue":"1","key":"7440_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12282-014-0540-4","volume":"23","author":"S Kuba","year":"2016","unstructured":"Kuba S, Ishida M, Nakamura Y, Taguchi K, Ohno S (2016) Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer. Breast Cancer 23(1):128\u2013133. https:\/\/doi.org\/10.1007\/s12282-014-0540-4","journal-title":"Breast Cancer"},{"issue":"6","key":"7440_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","volume":"154","author":"A Freites-Martinez","year":"2018","unstructured":"Freites-Martinez A, Shapiro J, Chan D et al (2018) Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol 154(6):670\u2013675. https:\/\/doi.org\/10.1001\/jamadermatol.2018.0454","journal-title":"JAMA Dermatol"},{"issue":"11","key":"7440_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00520-009-0769-1","volume":"18","author":"M Gandhi","year":"2010","unstructured":"Gandhi M, Oishi K, Zubal B, Lacouture ME (2010) Unanticipated toxicities from anticancer therapies: survivors\u2019 perspectives. Support Care Cancer 18(11):1461\u20131468. https:\/\/doi.org\/10.1007\/s00520-009-0769-1","journal-title":"Support Care Cancer"},{"issue":"Suppl 1","key":"7440_CR10","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1111\/ics.12735","volume":"43","author":"JP Sacha","year":"2021","unstructured":"Sacha JP, Caterino TL, Fisher BK et al (2021) Development and qualification of a machine learning algorithm for automated hair counting. Int J Cosmet Sci 43(Suppl 1):S34\u2013S41. https:\/\/doi.org\/10.1111\/ics.12735","journal-title":"Int J Cosmet Sci"},{"issue":"6","key":"7440_CR11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","volume":"155","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Chan D, Sibaud V et al (2019) Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia. JAMA Dermatol 155(6):724\u2013728. https:\/\/doi.org\/10.1001\/jamadermatol.2018.5071","journal-title":"JAMA Dermatol"},{"key":"7440_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.005","author":"J Kang","year":"2022","unstructured":"Kang J, Lee JW, Kwon O (2022) Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: a retrospective cohort study. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.005","journal-title":"J Am Acad Dermatol"},{"key":"7440_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jdcr.2022.01.035","volume":"22","author":"A Lyakhovitsky","year":"2022","unstructured":"Lyakhovitsky A, Segal O, Maly A, Zlotogorski A, Barzilai A (2022) Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil. JAAD Case Rep 22:64\u201367. https:\/\/doi.org\/10.1016\/j.jdcr.2022.01.035","journal-title":"JAAD Case Rep"},{"issue":"5","key":"7440_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jaad.2016.12.027","volume":"76","author":"A Fonia","year":"2017","unstructured":"Fonia A, Cota C, Setterfield JF, Goldberg LJ, Fenton DA, Stefanato CM (2017) Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: clinicopathologic findings in a cohort of 10 patients. J Am Acad Dermatol 76(5):948\u2013957. https:\/\/doi.org\/10.1016\/j.jaad.2016.12.027","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"7440_CR15","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","volume":"14","author":"R Paus","year":"2013","unstructured":"Paus R, Haslam IS, Sharov AA, Botchkarev VA (2013) Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 14(2):e50\u2013e59. https:\/\/doi.org\/10.1016\/S1470-2045(12)70553-3","journal-title":"Lancet Oncol"},{"issue":"2","key":"7440_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","volume":"63","author":"B Tallon","year":"2010","unstructured":"Tallon B, Blanchard E, Goldberg LJ (2010) Permanent chemotherapy-induced alopecia: case report and review of the literature. J Am Acad Dermatol 63(2):333\u2013336. https:\/\/doi.org\/10.1016\/j.jaad.2009.06.063","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"7440_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","volume":"84","author":"M Randolph","year":"2021","unstructured":"Randolph M, Tosti A (2021) Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol 84(3):737\u2013746. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.1009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"7440_CR18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1096\/fj.07-099424","volume":"22","author":"K Shorter","year":"2008","unstructured":"Shorter K, Farjo NP, Picksley SM, Randall VA (2008) Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J 22(6):1725\u20131736. https:\/\/doi.org\/10.1096\/fj.07-099424","journal-title":"FASEB J"},{"issue":"8","key":"7440_CR19","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.18632\/oncotarget.1886","volume":"5","author":"CL Hsu","year":"2014","unstructured":"Hsu CL, Liu JS, Lin AC, Yang CH, Chung WH, Wu WG (2014) Minoxidil may suppress androgen receptor-related functions. Oncotarget 5(8):2187\u20132197. https:\/\/doi.org\/10.18632\/oncotarget.1886","journal-title":"Oncotarget"},{"issue":"1","key":"7440_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","volume":"82","author":"PM Ramos","year":"2020","unstructured":"Ramos PM, Sinclair RD, Kasprzak M, Miot HA (2020) Minoxidil 1\u00a0mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial. J Am Acad Dermatol 82(1):252\u2013253. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.060","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"7440_CR21","doi-asserted-by":"publisher","first-page":"e15131","DOI":"10.1111\/dth.15131","volume":"34","author":"S Vahabi-Amlashi","year":"2021","unstructured":"Vahabi-Amlashi S, Layegh P, Kiafar B et al (2021) A randomized clinical trial on therapeutic effects of 0.25 mg oral minoxidil tablets on treatment of female pattern hair loss. Dermatol Ther 34(6):e15131. https:\/\/doi.org\/10.1111\/dth.15131","journal-title":"Dermatol Ther"},{"issue":"2","key":"7440_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jaad.2019.04.054","volume":"81","author":"J Jimenez-Cauhe","year":"2019","unstructured":"Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R et al (2019) Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. J Am Acad Dermatol 81(2):648\u2013649. https:\/\/doi.org\/10.1016\/j.jaad.2019.04.054","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"7440_CR23","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jaad.2020.10.097","volume":"84","author":"B Olamiju","year":"2021","unstructured":"Olamiju B, Craiglow BG (2021) Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls. J Am Acad Dermatol 84(6):1689\u20131691. https:\/\/doi.org\/10.1016\/j.jaad.2020.10.097","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"7440_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s40257-018-0409-y","volume":"20","author":"JR Stoehr","year":"2019","unstructured":"Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S (2019) Off-label use of topical minoxidil in alopecia: a review. Am J Clin Dermatol 20(2):237\u2013250. https:\/\/doi.org\/10.1007\/s40257-018-0409-y","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"7440_CR25","doi-asserted-by":"publisher","first-page":"e14234","DOI":"10.1111\/dth.14234","volume":"33","author":"M Vastarella","year":"2020","unstructured":"Vastarella M, Cantelli M, Patr\u00ec A, Annunziata MC, Nappa P, Fabbrocini G (2020) Efficacy and safety of oral minoxidil in female androgenetic alopecia. Dermatol Ther 33(6):e14234. https:\/\/doi.org\/10.1111\/dth.14234","journal-title":"Dermatol Ther"},{"issue":"6","key":"7440_CR26","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s13555-020-00448-x","volume":"10","author":"R Panchaprateep","year":"2020","unstructured":"Panchaprateep R, Lueangarun S (2020) Efficacy and safety of oral minoxidil 5 mg once daily in the treatment of male patients with androgenetic alopecia: an open-label and global photographic assessment. Dermatol Ther (Heidelb) 10(6):1345\u20131357. https:\/\/doi.org\/10.1007\/s13555-020-00448-x","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"7440_CR27","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1111\/jdv.17731","volume":"36","author":"L Yin","year":"2022","unstructured":"Yin L, Svigos K, Gutierrez D, Peterson E, Lo Sicco K, Shapiro J (2022) Low-dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients. J Eur Acad Dermatol Venereol 36(3):e200\u2013e202. https:\/\/doi.org\/10.1111\/jdv.17731","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"7440_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/0284186X.2020.1738547","volume":"59","author":"D Eiger","year":"2020","unstructured":"Eiger D, Wagner M, Ponde NF, Nogueira MS, Buisseret L, de Azambuja E (2020) The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4\/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC). Acta Oncol 59(6):723\u2013725. https:\/\/doi.org\/10.1080\/0284186X.2020.1738547","journal-title":"Acta Oncol"},{"key":"7440_CR29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e12537","author":"D Chan","year":"2019","unstructured":"Chan D, Martinez ADF, Goldfarb SB, Modi S, Gajria D, Lacouture ME (2019) CDK4\/6 plus aromatase inhibitor-induced alopecia in breast cancer patients. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.e12537","journal-title":"J Clin Oncol"},{"issue":"5","key":"7440_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1524-6175.2004.03585.x","volume":"6","author":"DA Sica","year":"2004","unstructured":"Sica DA (2004) Minoxidil: an underused vasodilator for resistant or severe hypertension. J Clin Hypertens (Greenwich) 6(5):283\u2013287. https:\/\/doi.org\/10.1111\/j.1524-6175.2004.03585.x","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"7440_CR31","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","volume":"84","author":"S Vano-Galvan","year":"2021","unstructured":"Vano-Galvan S, Pirmez R, Hermosa-Gelbard A et al (2021) Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol 84(6):1644\u20131651. https:\/\/doi.org\/10.1016\/j.jaad.2021.02.054","journal-title":"J Am Acad Dermatol"},{"key":"7440_CR32","doi-asserted-by":"publisher","first-page":"45366","DOI":"10.1038\/srep45366","volume":"7","author":"YF Chen","year":"2017","unstructured":"Chen YF, Chen LH, Yeh YM et al (2017) Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy. Sci Rep 7:45366. https:\/\/doi.org\/10.1038\/srep45366","journal-title":"Sci Rep"},{"key":"7440_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fphar.2020.00577","volume":"11","author":"D Fukushiro-Lopes","year":"2020","unstructured":"Fukushiro-Lopes D, Hegel AD, Russo A et al (2020) Repurposing Kir6\/SUR2 channel activator minoxidil to arrests growth of gynecologic cancers. Front Pharmacol 11:577. https:\/\/doi.org\/10.3389\/fphar.2020.00577","journal-title":"Front Pharmacol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07440-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07440-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07440-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T16:20:17Z","timestamp":1730218817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07440-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["7440"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07440-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,4]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AMK, RER, KFK, AP, LK, SD, DG, DEL, JFB, MNF, and MD have no disclosures. SBG is a consultant for Procter & Gamble and Sermonix Pharmaceuticals and receives research funding from Paxman and Sprout Pharmaceuticals. TAT is a consultant for Agendia, AstraZeneca, Athenex, Ayala Pharmaceuticals, Blueprint Medicines, Daiichi Sankyo, Eisai, Ellipses Pharma, Exact Sciences, Foundation Medicine, Fuji Pharma, Genentech\/Roche, Gilead Sciences, Ionis Pharmaceuticals, ITeos Therapeutics, Merck, Pfizer, Puma Biotechnology, and Seattle Genetics. TAT receives research funding from Astellas Pharma, AstraZeneca, Ayala Pharmaceuticals, Carrick Pharm, Daiichi Sankyo, Eisai, Genentech\/Roche, Immunomedics, Innocrin Pharma, Novartis, and Pfizer. AG receives research funding from BioAtla, Bristol-Myers Squibb, Innocrin Pharma, Merck, Novartis, OncoTherapy Science, Pfizer, Roche, and Zenith Epigenetics. BMD is employed by Canfield Scientific, Inc. VR is a consultant for Inhabit Brands, Inc. JS is a consultant for Shook, Hardy and Bacon, Pfizer and Lilly. AM receives research funding from Incyte Corporation and Amryt Pharma; serves on the advisory board for Blueprint Medicines, Alira Health, and Janssen; and receives royalties from UpToDate. MEL has a consultant role with Johnson and Johnson, Novocure, QED, Bicara, Janssen, Novartis, F. Hoffmann-LaRoche AG, EMD Serono, Astrazeneca, Innovaderm, Deciphera, DFB, Azitra, Kintara, RBC\/La Roche Posay, Trifecta, Varsona, Genentech, Loxo, Seattle Genetics, Lutris, On Quality, Azitra, Roche, Oncoderm, NCODA, and Apricity. MEL receives research funding from Lutris, Paxman, Novocure, J&J, US Biotest, OQL, Novartis, and Astrazeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a retrospective study. The Institutional Review Board of Memorial Sloan Kettering Cancer Center has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}